DE69118978D1 - Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen - Google Patents

Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen

Info

Publication number
DE69118978D1
DE69118978D1 DE69118978T DE69118978T DE69118978D1 DE 69118978 D1 DE69118978 D1 DE 69118978D1 DE 69118978 T DE69118978 T DE 69118978T DE 69118978 T DE69118978 T DE 69118978T DE 69118978 D1 DE69118978 D1 DE 69118978D1
Authority
DE
Germany
Prior art keywords
treatment
inflammatory diseases
keto prostaglandins
prostaglandins
keto
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69118978T
Other languages
English (en)
Other versions
DE69118978T2 (de
Inventor
Ryuji Ueno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DE69118978D1 publication Critical patent/DE69118978D1/de
Publication of DE69118978T2 publication Critical patent/DE69118978T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69118978T 1990-07-10 1991-07-03 Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen Expired - Lifetime DE69118978T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18496390 1990-07-10

Publications (2)

Publication Number Publication Date
DE69118978D1 true DE69118978D1 (de) 1996-05-30
DE69118978T2 DE69118978T2 (de) 1996-11-14

Family

ID=16162415

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69118978T Expired - Lifetime DE69118978T2 (de) 1990-07-10 1991-07-03 Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen

Country Status (10)

Country Link
US (1) US5346921A (de)
EP (1) EP0467564B1 (de)
JP (1) JP2562239B2 (de)
KR (1) KR100195430B1 (de)
AT (1) ATE137116T1 (de)
CA (1) CA2046069C (de)
DE (1) DE69118978T2 (de)
DK (1) DK0467564T3 (de)
ES (1) ES2089136T3 (de)
GR (1) GR3019760T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508302A (en) * 1994-09-28 1996-04-16 American Home Products Corporation Phospholipase A2 inhibitors
HU223345B1 (hu) 1995-12-20 2004-08-30 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Eljárás alfa, béta-telítetlen ketonok sztereoszelektív redukciójára
DK0857718T3 (da) * 1996-06-10 2002-12-16 Sucampo Ag Endothelinantagonist
CN1206997C (zh) 1997-11-28 2005-06-22 株式会社·R-技术上野 内皮缩血管肽拮抗剂
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
DE60010913T2 (de) 1999-10-15 2005-06-09 Sucampo Ag Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung
DE60225266T2 (de) * 2001-05-18 2009-03-19 Sucampo Ag Zusammensetzung mit induzierendem kathartischen effekt
CA2458230A1 (en) * 2001-08-23 2003-03-06 Sucampo Ag Method and composition for treatment of ocular hypertension and glaucoma
AR037524A1 (es) 2001-11-14 2004-11-17 Sucampo Ag Unidad de dosificacion que comprende un analogo de prostaglandina para el tratamiento de la constipacion
CA2600331C (en) * 2005-03-04 2014-07-08 Sucampo Ag Use of 11-deoxy-prostaglandin for treating peripheral vascular diseases
US20060281818A1 (en) * 2005-03-21 2006-12-14 Sucampo Ag, North Carolina State University Method for treating mucosal disorders
US20070037193A1 (en) * 2005-08-12 2007-02-15 Rong-Hwa Lin Modulation of peroxisome proliferator-activated receptors
US20090082442A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched lubiprostone
TW201309301A (zh) * 2011-06-21 2013-03-01 R Tech Ueno Ltd 處置發炎性疾病、過敏性疾病以及自體免疫疾病用之醫藥組成物
KR102578588B1 (ko) * 2021-07-22 2023-09-14 정찬희 자석이 구비된 도어 잠금장치

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2321876A1 (fr) * 1975-08-29 1977-03-25 Roussel Uclaf Nouveaux derives cyclopentaniques, leur procede de preparation et leur application comme medicaments
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
JPS59134746A (ja) * 1982-11-05 1984-08-02 ザ，プロクタ−，エンド，ギヤンブル，カンパニ− 新規プロスタグランジン類似体
EP0153858A3 (de) * 1984-02-29 1985-12-11 The Upjohn Company Therapeutische Anwendung von Protaglandinen
US4612330A (en) * 1985-02-04 1986-09-16 Eli Lilly And Company Antiinflammatory method
GB8625325D0 (en) * 1986-10-22 1986-11-26 Glaxo Group Ltd Chemical compounds
CA1323364C (en) * 1987-01-28 1993-10-19 Ryuzo Ueno Prostaglandins e and anti ulcer agents containing same
CA1322749C (en) * 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) * 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
ES2038289T3 (es) * 1987-05-15 1993-07-16 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Utilizacion de 15-ceto-pges para la fabricacion de un medicamento para aumentar la temperatura corporal.
ATE108330T1 (de) * 1987-09-18 1994-07-15 R Tech Ueno Ltd Hypotensive okulare mittel.
GB2210556B (en) * 1987-10-02 1991-07-17 Ueno Seiyaku Oyo Kenkyujo Kk The use of 15-keto-16-halo-prostaglandins in cathartic compositions
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
AU616502B2 (en) * 1988-04-22 1991-10-31 Medvet Science Pty. Ltd. Treatment of inflammatory disorders in humans
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
AU619543B2 (en) * 1988-05-11 1992-01-30 Sucampo Ag Use of 15-ketoprostaglandin e or f compounds for uterine contraction
ES2055051T3 (es) * 1988-05-23 1994-08-16 Ueno Seiyaku Oyo Kenkyujo Kk Un metodo para la fabricacion de un medicamento eficaz para aumentar la presion sanguinea.
JP2515442B2 (ja) * 1990-05-01 1996-07-10 株式会社上野製薬応用研究所 膵臓疾患処置剤

Also Published As

Publication number Publication date
JP2562239B2 (ja) 1996-12-11
KR100195430B1 (ko) 1999-06-15
EP0467564B1 (de) 1996-04-24
ATE137116T1 (de) 1996-05-15
GR3019760T3 (en) 1996-07-31
DE69118978T2 (de) 1996-11-14
ES2089136T3 (es) 1996-10-01
CA2046069A1 (en) 1992-01-11
KR920002151A (ko) 1992-02-28
EP0467564A2 (de) 1992-01-22
DK0467564T3 (da) 1996-05-13
JPH0532551A (ja) 1993-02-09
US5346921A (en) 1994-09-13
EP0467564A3 (en) 1992-07-08
CA2046069C (en) 2002-04-09

Similar Documents

Publication Publication Date Title
ATE169219T1 (de) Behandlung von katarakt mit 15-keto- prostaglandinderivaten
ATE82121T1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE69118978D1 (de) Behandlung von entzündlichen Erkrankungen mit 15-Ketoprostaglandinen
ATE143263T1 (de) Behandlung von neurodegenerativen erkrankungen
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
DE69213057D1 (de) Stimulierung von Wundheilung mit 15-Keto-prostaglandinverbindungen
ATE174221T1 (de) Behandlung von pankreaskrankheit mit 15-keto- prostaglandin e-derivaten
DE69024744D1 (de) Behandlung der hepatobilären Erkrankung mit 15-Ketoprostaglandin-Derivaten
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
ATE129895T1 (de) Behandlung von pulmonarer disfunktion mit 15-keto-prostaglandin-derivaten.
ATE146964T1 (de) Behandlung von katarakt mit prostacyclinverbindungen
DE69124415D1 (de) Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SUCAMPO AG, ZUG, CH